Repurposing medications to prevent psychosis
- PMID: 41145753
- PMCID: PMC12559349
- DOI: 10.1038/s44184-025-00169-z
Repurposing medications to prevent psychosis
Abstract
Individuals who experience schizophrenias often had premorbid signs. However, they rarely develop psychosis until adolescence or young adulthood, a period of brain remodeling. Current efforts to reduce risk for psychosis have shown only modest benefit. This paper reviews evidence on mechanisms that may underlie the development of psychosis. Based on that evidence, it identifies existing medications that target these mechanisms and may be repurposed to prevent progression to psychosis.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
References
-
- Knudsen, C. B. et al. Early childhood neurocognition in relation to middle childhood psychotic experiences in children at familial high risk of schizophrenia or bipolar disorder and population-based controls: the Danish high risk and resilience study. Schizophr. Bull.49, 756–767 (2023). - PMC - PubMed
-
- Benrimoh, D. et al. On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis. Mol. Psychiatry29, 1361–1381 (2024). - PubMed
-
- Insel, T. R. Rethinking schizophrenia. Nature468, 187–193 (2010). - PubMed
Publication types
LinkOut - more resources
Full Text Sources
